biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
05:41 AI-matched pill cut colon polyp tissue in 13 of 15 people, maker says✦05:39 Nasal spray cut a brain inflammation sign in progressive MS, maker says✦05:36 Australia approves a daily Wegovy pill as an option to weekly shots✦05:36 One-time gene-editing drip partly fixed an inherited liver gene in a man✦23:41 Melanoma cell therapy controlled by an approved drug enrolls new groups✦23:41 ADHD drugs may ease perimenopause brain fog, early review suggests✦23:36 $1.55 billion pill for rare muscle disease failed big trial, maker says✦17:44 Lab study points to a protein that may help drive aging in testicles✦05:41 AI-matched pill cut colon polyp tissue in 13 of 15 people, maker says✦05:39 Nasal spray cut a brain inflammation sign in progressive MS, maker says✦05:36 Australia approves a daily Wegovy pill as an option to weekly shots✦05:36 One-time gene-editing drip partly fixed an inherited liver gene in a man✦23:41 Melanoma cell therapy controlled by an approved drug enrolls new groups✦23:41 ADHD drugs may ease perimenopause brain fog, early review suggests✦23:36 $1.55 billion pill for rare muscle disease failed big trial, maker says✦17:44 Lab study points to a protein that may help drive aging in testicles
← All story threadsSTORY THREAD

Recursion's AI-found pill for an inherited colon polyp disease.

1 report so far. New developments are added to this thread as they happen.

  1. Nov 3, 2026
    MID-STAGE RESULTS; BIGGER TRIAL PLANNED FOR 2027Company results · 15 people

    AI-matched pill cut colon polyp tissue in 13 of 15 people, maker says

    Recursion says its daily pill reduced polyp tissue in most people with an inherited colon polyp disease and plans a larger trial, aimed at approval, in the second half of 2027.